SPI-1005 for the Treatment of Meniere's Disease (Open Label)
SPI-1005 for the Treatment of Meniere's Disease (Open Label)
Active, not recruiting · NCT06859788 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SPI-1005 for the Treatment of Meniere's Disease (Open Label) | Dizziness, Ear Diseases, Meniere disease, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Vertigo, endolymphatic hydrops, hearing disorder, hearing loss disorder, inner ear disorder, nervous system disorder, otorhinolaryngologic disease, tinnitus, vestibular disorder | Active, not recruiting | Phase 3 | 2026-07-13 | NCT06859788 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sound Pharmaceuticals, Incorporated | 3 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| ENT and Allergy Associates of Florida | Delray Beach | United States | 1 |
| ENT and Allergy Associates of Florida | Boynton Beach | United States | 1 |
| ENT and Allergy Associates, LLP | New York | United States | 1 |
| Medical College of Wisconsin | Milwaukee | United States | 483 |
| Medical University of South Carolina | Charleston | United States | 628 |
| Northwell Health | New Hyde Park | United States | 13 |
| The House Institute | Los Angeles | United States | 1 |
| Thomas Jefferson University | Philadelphia | United States | 165 |
| University of Texas Southwestern | Dallas | United States | 73 |